Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Sterigenics International LLC, a global provider of contract sterilization, gamma technologies and medical isotopes, and a portfolio company of Warburg Pincus and GTCR, has announced expansion at their Wiesbaden, Germany location.
read more
Thursday, November 02, 2017
Sterigenics International has acquired Toxikon Europe N.V., the European division of Toxikon Corporation, a Bedford, Mass.-based preclinical contract research organization.
read more
Thursday, August 18, 2016
Sterigenics International LLC and subsidiary Nordion have entered into an agreement as part of REVISS's Solvent Members Voluntary Liquidation to purchase REVISS Services (UK) Limited and its US subsidiary REVISS Services Incorporated. The transaction...
read more
Wednesday, January 06, 2016
Sterigenics International, a global provider of contract sterilization, gamma technologies and medical isotopes, has announced expansion at their Forth Worth, Texas location, with the addition of a new gamma cell that will increase capacity by 30%.
read more
Thursday, August 03, 2017
Sterigenics International announced the completion of another expansion to its Fort Worth, Texas facility, making it the largest sterilization facility in the company’s global network.
read more
Wednesday, December 21, 2016
UK-based contract development and manufacturing organisation (CDMO) Sterling Pharma Solutions has established a toll processing agreement with TPI Enterprises to manufacture Codeine Phosphate (CPO) for sale in the UK market.
read more
Wednesday, December 16, 2020
Sterling Pharma has announced a new strategic partnership with ADC Bio, a UK based biotechnology company specializing in antibody drug conjugates.
read more
Sterling Pharma Solutions has announced the expansion of its pilot plant facility is now operational at its UK site following a £6million investment last year.
read more
Sterling Pharma Solutions has started large-scale production of Nanologica’s silica particles.
read more
Sterling Pharma Solutions is investing £6m into its pilot plant facility at its UK site to enhance its scale-up and small to midscale commercial API manufacturing capabilities.
read more
Tuesday, October 06, 2020
Sterling Pharma Solutions, has announced its acquisition of Alcami’s Germantown, Wisconsin facility in the US.
read more
Sterling Pharma Solutions has opened its new Material Science Centre (MSC), after announcing the investment last year.
read more
Wednesday, December 01, 2021
Sterling Pharma Solutions, a global contract development and manufacturing organization, announced an exclusive partnership with the University of Manchester Institute of Biotechnology (MIB), to support the development of a novel, low-cost ...
read more
GHO Capital has acquired a majority stake in Sterling Pharma Solutions, a specialist in complex and difficult to manufacture APIs.
read more
Global contract development and manufacturing organisation (CDMO), Sterling Pharma Solutions, has announced the acquisition of ADC Biotechnology, a UK based bioconjugation development services business specialising in antibody drug conjugates (ADCs).
read more